Cucurbitacin i inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells

Cancer

Volumn 117, Issue 13, 2011, Pages 2970-2985

  Hsu, Han Shui ^a,b   Huang, Pin I ^a,b   Chang, Yuh Lih ^a,b   Tzao, Ching ^c   Chen, Yi Wei ^a,b   Shih, Hsin Chin ^a,b   Hung, Shih Chieh ^a,b   Chen, Yu Chih ^a,b   Tseng, Ling Ming ^a,b   Chiou, Shih Hwa ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

cancer stem cells; CD133; cucurbitacin; lung cancer; radiochemoresistance.; signal transducer and activator of transcription 3

Indexed keywords

ANTINEOPLASTIC AGENT; CD133 ANTIGEN; CISPLATIN; CUCURBITACIN I; DOXORUBICIN; FLUOROURACIL; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; PROTEIN BCL 2; PROTEIN BCL XL; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER RESISTANCE; CARCINOGENICITY; CELL DIFFERENTIATION; CHEMORADIOTHERAPY; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; LUNG NON SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

AGED; ANIMALS; ANTIGENS, CD; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; CELL SEPARATION; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOPROTEINS; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PEPTIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; STAT3 TRANSCRIPTION FACTOR; TRITERPENES; TUMOR CELLS, CULTURED;

EID: 79959622792     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25869     Document Type: Article

References (34)

1. Spira A, Ettinger DS., Multidisciplinary management of lung cancer. N Engl J Med. 2004; 350: 379-392. (Pubitemid 38101633)
2. Hsu HS, Wen CK, Tang YA, et al. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer. Clin Cancer Res. 2005; 11: 5410-5416.
3. Socinski MA, Bogart JA., Limited-stage small-cell lung cancer: the current status of combined-modality therapy. J Clin Oncol. 2007; 25: 4137-4145. (Pubitemid 47492958)
4. Bernstein ED, Herbert SM, Hanna NH., Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer. Ann Surg Oncol. 2006; 13: 291-301. (Pubitemid 43255911)
5. Lam WK, Watkins DN., Lung cancer: future directions. Respirology. 2007; 12: 471-477. (Pubitemid 46961832)
6. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004; 432: 396-401. (Pubitemid 39551674)
7. Mizrak D, Brittan M, Alison MR., CD133: molecule of the moment. J Pathol. 2008; 214: 3-9.
8. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007; 445: 111-115. (Pubitemid 46067311)
9. Miki J, Furusato B, Li H, et al. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res. 2007; 67: 3153-3161. (Pubitemid 46724852)
10. Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 2007; 132: 2542-2556. (Pubitemid 46890873)
11. Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008; 15: 504-514. (Pubitemid 351267301)
12. Jiang T, Collins BJ, Jin N, et al. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res. 2009; 69: 845-854.
13. Chen YC, Hsu HS, Chen YW, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One. 2008;3:e2637. Accessed on July 15, 2010.
14. Bertolini G, Roz L, Perego P, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A. 2009; 106: 16281-16286.
15. Bowman T, Garcia R, Turkson J, Jove R., STATs in oncogenesis. Oncogene. 2000; 19: 2474-2488. (Pubitemid 30339203)
16. Bromberg J., Stat proteins and oncogenesis. J Clin Invest. 2002; 109: 1139-1142. (Pubitemid 34496590)
17. Bromberg JF., Activation of STAT proteins and growth control. Bioessays. 2001; 23: 161-169. (Pubitemid 32116649)
18. Epling-Burnette PK, Liu JH, Catlett-Falcone R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest. 2001; 107: 351-362.
19. Sanchez-Ceja SG, Reyes-Maldonado E, Vazquez-Manriquez ME, Lopez-Luna JJ, Belmont A, Gutierrez-Castellanos S., Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma. Lung Cancer. 2006; 54: 163-168. (Pubitemid 44810856)
20. Kim HS, Park YH, Lee J, et al. Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray. Cancer. 2010; 116: 676-685.
21. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell. 1999; 98: 295-303. (Pubitemid 29380565)
22. Niu G, Wright KL, Ma Y, et al. Role of Stat3 in regulating p53 expression and function. Mol Cell Biol. 2005; 25: 7432-7440. (Pubitemid 41170107)
23. Yu H, Jove R., The STATs of cancer-new molecular targets come of age. Nat Rev Cancer. 2004; 4: 97-105. (Pubitemid 38198738)
24. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM., Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 2003; 63: 1270-1279. (Pubitemid 36348705)
25. Chiou SH, Kao CL, Chen YW, et al. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One. 2008;3:e2090. Accessed on July 15, 2010.
26. Chiou SH, Chen SJ, Chang YL, et al. MafA promotes the reprogramming of placenta-derived multipotent stem cells into pancreatic islets-like and insulin-positive cells [published online ahead of print February J Cell Mol Med. 2010; 16.
27. Kao CL, Huang PI, Tsai PH, et al. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int J Radiat Oncol Biol Phys. 2009; 74: 219-228.
28. Salnikov AV, Gladkich J, Moldenhauer G, Volm M, Mattern J, Herr I., CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients. Int J Cancer. 2010; 126: 950-958.
29. Wang H, Lathia JD, Wu Q, et al. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells. 2009; 27: 2393-2404.
30. Jordan CT, Guzman ML, Noble M., Cancer stem cells. N Engl J Med. 2006; 355: 1253-1261. (Pubitemid 44427449)
31. Kruser TJ, Armstrong EA, Ghia AJ, et al. Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer. Int J Radiat Oncol Biol Phys. 2008; 72: 534-542.
32. Yeh HH, Lai WW, Chen HH, Liu HS, Su WC., Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene. 2006; 25: 4300-4309. (Pubitemid 44100500)
33. Lee DH, Iwanski GB, Thoennissen NH., Cucurbitacin: ancient compound shedding new light on cancer treatment. ScientificWorldJournal. 2010; 10: 413-418.
34. Ho JN, Kang GY, Lee SS, et al. Bcl-XL and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells. Cancer Sci. 2010; 101: 1417-1423.